XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Mar. 21, 2016
Summary of Significant Accounting Policies (Details) [Line Items]        
Common stock, par value (in Dollars per share)       $ 0.001
Common stock authorized (in Shares)       360,000,000
Cash and cash equivalents $ 1,134,959   $ 85,265  
Restricted cash equivalents $ 656,919   $ 1,306,463  
Account receivable 83.28%      
Impairment of equity investments $ 0 $ 0    
Labor pension fund percentage 6.00%      
Percentage of monthly contribution 6.00%      
Employee benefits amount $ 2,804 3,337    
Employee stock-based compensation expenses 0 0    
Non-employee stock-based compensation expenses $ 366,489 $ 4,692,003    
Benefit percentage 50.00%      
Rgene Corporation [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Total revenues, percentage 84.78%      
GLIA LLC [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Total revenues, percentage 42.51%      
Chartwell RX Sciences, LLC [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Total revenues, percentage 35.27%      
GRAS Associates [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Total revenues, percentage 100.00%      
Biotech Industries [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Total revenues, percentage 82.90%      
Agriculture Industries [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Total revenues, percentage 15.50%      
Biokey [Member]        
Summary of Significant Accounting Policies (Details) [Line Items]        
Account receivable 10.75%